Mayne Pharma reported $387.27M in Debt for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Ansell ANN:AU $ 561.9M 46.4M
Cochlear COH:AU $ 266.1M 1.8M
CSL CSL:AU $ 5.57B 238.2M
Ecofibre Ltd EOF:AU 10.77M 261K
Healius Ltd HLS:AU $ 1.47B 37.3M
Integral Diagnostics Ltd IDX:AU 350.36M 42.01M
Nanosonics Ltd NAN:AU $ 5.6M 3.11M
Next Science Ltd NXS:AU 276.04K 112.35K
Polynovo Ltd PNV:AU 10M 7.96K
Probiotec Ltd PBP:AU 95.54M 1.75M
Ramsay Health Care RHC:AU $ 8.85B 1.7B
ResMed RMD:AU $ 680.7M 723K
Sigma Healthcare Ltd SIG:AU 323.43M 81.42M
Sonic Healthcare SHL:AU $ 3.22B 16.58M
Telix Pharmaceuticals Ltd TLX:AU 2.54M 843K